What can we learn from parents about enhancing participation in pharmacovigilance? (Q36729977)

15 August 2017

What can we learn from parents about enhancing participation in pharmacovigilance? (English)

1 reference

15 August 2017

Matthew Peak

4

0 references

Bridget Young

object named as

Bridget Young

8

0 references

Mark A. Turner

object named as

Mark A Turner

7

0 references

Munir Pirmohamed

object named as

Munir Pirmohamed

5

0 references

author name string

Janine Arnott

1

1 reference

15 August 2017

Hannah Hesselgreaves

2

1 reference

15 August 2017

Anthony J Nunn

3

1 reference

15 August 2017

Rosalind L Smyth

6

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

British Journal of Clinical Pharmacology

15 August 2017

1 reference

15 August 2017

75

1 reference

15 August 2017

4

1 reference

15 August 2017

1109-1117

1 reference

Experiences with adverse drug reaction reporting by patients: an 11-country survey

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Views of parents and pharmacists following participation in a paediatric pharmacovigilance study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Public awareness and views on unlicensed use of medicines in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Under-reporting of adverse drug reactions : a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Patients' role in reporting adverse drug reactions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Young adults with cancer: parents' interactions with health care professionals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Unlicensed and off label prescription of drugs to children: population based cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Adverse drug reactions: definitions, diagnosis, and management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

What worries parents when their preschool children are acutely ill, and why: a qualitative study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Risky business: challenges in vaccine risk communication

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UK.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612729

Lack of effect of the European guidance on clinical investigation of medicines in children

5 September 2018

1 reference

12 December 2020

Restoring confidence in vaccines by explaining vaccine safety monitoring: is a targeted approach needed?

1 reference

12 December 2020

Parents with doubts about vaccines: which vaccines and reasons why

1 reference

12 December 2020

New rules will allow EU patients to report drug concerns directly

1 reference

12 December 2020

10.1111/J.1365-2125.2012.04441.X

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference